patterns of alteration of the connective tissue matrix as a whole are predictable for a disease, and even then, these are nonspe cific. Moreover, there appears to be a limited repertoire of morphologic alterations and this affects (with few exceptions) only the reticular dermis.
It is also difficult to assign a given morphologic change to a specific biochemical defect, for the same alterations in a fibril or fiber can occur in instances where there is no obvious similarity in the molecular defect. Thus, the changes we observe seem to indicate that the dermal connective tissue matrix elicits a coordinated response to a single gene change, i.e., an alteration in one structural protein, regardless of the level of alteration in the biosynthetic pathway, may influence not only that protein but also the deposition and structure of others, ultimately modifying the overall architecture and mechanical properties of the tissue. In this sense, then, the structural abnormalities bear a closer relationship with the clinical findings than with biochemical defect.
This review is limited to a discussion of the alterations of collagen and elastic connective tissue as they occur in the skin, ignoring the fact that in some of the diseases (e.g., osteogenesis imperfecta, Marfan syndrome) the organ system primarily in volved is other than the skin. Most of the structural data are from our O\vn published or new (*) studies. These results are compared with or supplemented by recent findings of others, and, finally, discussed in the context of the biochemical altera tions(s) described for the disease. The data are not exhaustive but were selected to demonstrate the major patterns of change we have observed after surveying many patients affected with each disorder. From the summary charts, it is clear that even though patterns of change can be recognized, each disease exhibits substantial heterogeneity in both structural and bio chemical abnormalities.
MATERIALS AND METHODS
Skin biopsy specimens from patients with a variety of inherited connective tissue disorders were obtained from the extensor surface of upper the arm. They were immersed in 1/2 strength Karnovksy's fixative (1) buffered in 0.1 M cacodylate buffer and fixed for 2-4 hr in cold. Samples were washed in buffer, postfixed in 1% OSO, ill distilled water for an additional hour, soaked in 1% aqueous uranyl acetate for 1 hr to stain en bloc, and dehydrated through a graded series of alcohols_ Samples for light microscopy and transmission electron mi croscopy were further dehydrated into propylene oxide and embedded in Epon by conventional methods [2] . For scanning electron microscopy samples were dehydrated through an alcohol-freon series into 1009" freon 113 (Genesolv) and critical point dried in the pressure chamber of a BOMAH critical point bomb using freon 13 as the transit ional fluid [21-Dried specimens were mounted on aluminum stubs, sputter coated with gold palladium alloy and viewed in an ETEC scanning electron microscopy at 20 kv accelerating voltage and in the secondary electron mode. Embedded specimens were prepared in 1 flm sections for light microscopy and 80 nm sections for TEM. Thick sections were stained by the method of Richardson [4] , thin sections were stained with 17< phosphotungstic acid in water, saturated uranyl acetate, and with lead citrate [5] and viewed in a Philips 201 transmission electron microscope.
RESULTS
Alterations in tissue architecture and in individual collagen and elastic fibers are found in the skin from patients with inherited disorders of connective tissue metabolism. The differ ent major alterations of each fiber type are described and related to the diseases in which they were observed ( Table 1) . In a subsequent section the simultaneous expression of collagen and elastic fiber alterations are summarized (Table II ) and the patterns of connective tissue which may be identified with a syndrome are discussed in relation to the biochemical defects (where known) identified for the disorder. The reader is referred to a previous paper in this symposium [6] for histologic and ultrastructural details of the normal dermis.
Alterations in Dermal Architecture
Normal skin thickness is regionally variable [7] , but in some disorders (e.g., EDS IV, some forms of the Marfan syndrome, cutis laxa) marked thinning of the dermis is a hallmark of the disease. This can reflect both a diminished quantity of collagen and a finer organization of collagen bundles. The overall con sequence is a dermis with "fine texture," which may lack the normal interweaving of fiber bundles, or with a laminated appearance. Laminar organization of the dermis is characteris tic of fetal dermis during late stages of development. Con versely, the dermis may become exaggerated in thickness and consist of unusually large, dense fiber bundles. In addition, the relationships of structurally normal or abnormal elastic fibers with collagen fiber bundles can be altered such that elastic fibers are embedded within bundles rather than peripheral to them. Other changes in collagen-elastic fiber bundle relationVol. 79, Supplement 1 ships can occur when one or both of the fibers is structurally abnormal.
Unfortunately, there are no thorough studies of the range of individual variation in dermal organization among normal in dividuals of the same age and at different stages of life. Without these data, evaluation of dermal architecture must be per formed cautiously and correlated with other more specific changes in the matrix of connective tissue biochemistry which could account for an overall modification.
Alterations in Collagen Fibrils
One of the first alterations of collagen fibrils identified in skin was the so-called ribbon-or rope-like fibril observed in the dermis of sheep and cattle with dermatosparaxis [9] [10] [11] [12] . In longitudinal section these fibrils appeared loosely wound and flat or helical (Fig 1) ; in cross section they had 3-4 irregular, thin, projecting arms which gave them the appearance of "hieroglyphics" (Fig 1) . Similar fibrils have also been reported in the skin of dermatosparactic cats [13, 14] and observed in a dermatosparactic dog (Holbrook KA, Counts DF, Byers PH, Hegreberg GA: unpublished observations). Only 2 ultrastruc tural studies of skin from patients with the same disorder (EDS VII, arthrochalasis multiplex congenital have been reported. In the frrst instance, skin structure was normal and in the second, collagen flowers (see below) were observed [15] [16] [17] .
Collagen flowers, wires, ropes, stars and aggregates have been used to describe another aberrant structure of the collagen fibril (Fig 2) . The appearance of the fibrils in cross section (Fig 2a) suggests the flower nomenclature but in longitudinal section each fibril appears as a loose assembly of component filament bundles which form wide diameter, twisted ropes (Fig 2b) . The normal 640 A banding pattern of collagen is preserved across all elements of these aggregated structures. Collagen flowers are among the most frequently observed deviations in fibril structure, a nonspecific alteration which has been observed in skin of patients with EDS Types I [18] [19] [20] , II [18] , III [18, 20] , V [20] , VI [18] , VII [17] and IX (*), Type I or (*), PXE [21-22], elastosis perforans serpiginosa (EPS) [25] , cutis laxa [24, *] , and the Buschke-Ollendorff Syndrome [25] . They also appear in actinically damaged skin [28] and can be formed in vitro from solutions of collagen and proteoglycan monomer in which the latter component is presumed to slow the rate of fibril assembly [27] . The serrated fibril (Fig 3a) described by Sevenich [20] appears to be a minor deviation of normal struc ture in the direction of the collagen flower and the highly irregular, almost hieroglyphic, fibril observed in 2 infants with EDS I (*) may be a variation of the collagen flowers, restricted in size and showing a broader spectrum of shapes (Fig 3b) . Collagen flowers usually account for a low percentage of the fibrils per fibril bundle. The remaining fibrils are usually normal in shape but abnormally large or small in diameter (see below).
Unravelled collagen fibrils have been observed in the dermis of one patient with a form of SED [29] and in another with EDS type I (*). In the first, fiber bundles were observed in which each fibril showed regions of dissociation along its length or at the ends where the banding pattern was lost and the component fIlaments were visible (Fig 4a) . The reticular dermis of the second patient showed a "corduroy" pattern and fibrils which were normal in structure, flower-like and flower-like but more unravelled (Fig 4b) . 'Unravelled" may be an unfortunate descriptive term because it implies dissociation of a once formed structure while, in fact, it is more likely that normal assembly is blocked during fibrillogenesis.
Collagen fibrils which are normal in shape can deviate mark edly in diameter from the normal range (Fig 5) . In certain disorders all fibrils are uniformly larger (EDS I [17, 18] ), II [18] , III [18, 20] , VI [18] , x-linked cutis laxa [29] ) or smaller than normal (EDS I and II [32] , IV [20, [33] [34] [35] [36] population of fibrils which span a range beyond the limits of either the normal maximum and minimum diameters (EDS II (*), EDS III (*), EDS IV [32, 33,*], EDS VII [37] , EDS VIII (*), cutis laxa (*)). Fibrils of large and small diameter have also been found in the dermis of patients with scleroderma [38] [39] [40] , multicentric reticulohistiocytoma [41] , in the dermis of the tight-skinned mouse [42] , after treatment with the lathryogens f3-aminopropionitrile (f3-APN) and penicillamine [43] or the steroids hydroxycortisone 17 -butyrate and fluocinolone aceto nide [46] , and in the dermis undergoing wound repair.
Alterations in Elastic Fibers
Alterations in elastic fibers are commonly observed in tissue from patients with diseases which primarily affect the collagen fibrils and in those where the elastic fiber appears to be the major abnormality. It has been stated that diseases of collagen metabolism are more often related to abnormalities in the biosynthesis of collagen than diseases of the elastic connective tissue, the latter being mainly degradative in nature [45) . Our morphologic studies suggest, instead, that alterations in elastin deposition (perhaps a consequence of abnormal synthesis and/ or secretion) are responsible for many of the elastic connective tissue abnormalities (particularly cutis laxa), hence these dis orders also may be disorders of connective tissue biosynthesis. Apparent degradative changes in elastic fibers are seen in the dermis more frequently when the disease is associated with a defect in collagen. Pathologic changes in elastic fibers, com pared with those of collagen fibers, are more difficult to distin guish from age-related changes. Age and environmentally in duced degradative alterations have been sorted out from met abolically induced changes by Braverman and Fonferko [46) . There is a remarkable lack of biochemical data, however, on the molecular abnormalities in connective tissue diseases which primarily affect elastic fibers.
Categories of elastic fiber alterations are more difficult to define than for collagen because the elastic fiber is made up of elastin (matrix) and microfibrillar (scaffolding) components. Thus changes in the composite fiber structure need to be identified in association with, or independent of, alterations in one or both components. Deviations in the amount, distribution and morphology of elastic fibers, in relation to changes in collagen, for each of the diseases studied are summarized in Table II. Like collagen, elastic fibers in the dermis can be deficient or excessive in quantity, form large and small fibers, assume abnormal shapes and patterns, and distribute irregularly in the dermis, sometimes integrated within collagen fiber bundles (Fig  6) . In some cases, the presumed increase is only an apparent increase and attributable to a reduction in the normal amount of collagen. Large, highly branched, fragmented (Fig 7) and irregularly shaped fibers, sometimes organized into reticular networks, have been observed (Fig 8) . These are often described as "moth-eaten."
Aside from the overall changes in fiber structure, there are also specific alterations in either the microfibrils or the elastin, although the microfibrils appear to be unusually constant and stable; they are present in tissue even when elastin is deficient. The only obvious alterations of microfibrils are in quantity and organization. Some elastic fibers appear to have excessive num bers of microfibrils embedded within the matrix and at the surface; others of them, particularly those deficient in elastin, show tangled rather than linearly oriented microfibrils (Fig 9a) . In some instances (e.g., cutix laxa, *), small or large amounts of unstained elastin (indicative of "mature" elastin) are deposited as disconnected globules (Fig 9b) , a diffuse reticulum along the microfibrillar scaffolding (Fig 9c) , or independent of the micro fibrils altogether (Fig 9a) . The elastin matrix also may appear reticular or granular and stain darkly with cationic dyes (Fig I (a, x 40,000; b, x 47,000 ) . (Fig lOb) .
Alterations in the Ground Substance
Although the proteoglycans (PGs) and glycosaminoglycans (GAGs) have a well recognized role in influencing assembly of the fibrous matrix proteins [48] , we have made no attempt to review structural changes in these components. To do so would have required special processing of tissue to preserve and iden tify these diffusely organized molecules. However, in Table II and in the following section we will point out instances where excessive accumulations of diffuse matrix molecules were ob served and discuss overall patterns of matrix changes in consid eration of the biochemistry of these molecules.
Concurrent Alterations in Collagenous and Elastic Fibers and Biochemical Consideration
We have described changes in the dermal architecture, alter ations in the specific fibrillar components and have illustrated the nonspecificity of these alterations for a single disease or biochemical defect. The alterations of collagen and elastic con nective tissue have been described as separate entities whereas in the majority of instances they occur concurrently ( consistent with our original contention that alterations in one component of the connective tissue influence the matrix as a whole. From the data summarized in Table II it is impossible to synthesize a pattern of structural change that describes the dermis of patients with certain inherited connective tissue disorders. For some of these disorders a biochemical defect also has been identified.
The dermis of the dermatosparactic animals shows one of the more consistent patterns of alteration. It is thin, finely textured, has small fiber bundles and hieroglyphic fibrils. The altered fibrils in affected animals are believed to be the result of abnormal packing of collagen molecules which retain the amino terminal extension peptides, a consequence of a defect in an amino terminal pro collagen peptidase enzyme [49-51]' A "dermal morphology" cannot be described from data on only two patients although neither appeared to have the same al tered fibril structure even though the consequence (retention of amino terminal propeptides) of the biochemical defect on the procollagen molecules in both individuals was the same. In one patient the enzyme (as in animals) was deficient [15] ; in the other, a defect in a portion of the 0:2 chain of type I pro collagen prevented normal cleavage by the pro collagen peptidase en zyme [16] .
The dermis from patients with the dominantly inherited forms of EDS (Types I-III) is usually of normal thickness but varies in density. In all individuals we have examined, the fibrils were normal or large in diameter and collagen flowers were present. Only one report [30] presents the opposite observation of small diameter fibrils in skin from patients with types I and II. It is possible that those measurements were made from fibrils at a different level of the dermis. Elastic fibrils have excessive microfibrils, are fragmented or are normal. The major alterations were seen in the collagen.
There is only one account of a biochemical defect in tissue Abnormal structure of elastic fibers identified in the dermis of different patients with dominant and recessive forms of cutis laxa. a, microfibrils appear to be tangled and to lack normal amounts of elastin matrix. b, Small globular deposits of elastin are associated with bundles of micro fibrils. c, Deposition of an abnormally small amount of elastin on the microfibrils gives a reticular appearing pattern of elastic fibers structure. d, The elastin matrix appears to be deposited independent of the microfibrils (a, x 18,000; b, x 25,000; c, x 12,000; d, x 10,5(0).
from patients with any of the dominant forms of EDS. Shinkai et al [52] reported an alteration in the ratio of PGs:GAGs secreted by cultured fibroblasts obtained from a patient with EDS I and inhibition of the conversion of pro collagen to colla gen. Unfortunately, morphological studies were not carried out in conjunction with the biochemical studies, thus we do not know if this patient expressed the structural alterations that fit our pattern. The influence of proteoglycan on both collagen and elastin fibril formation is well recognized [47, 53] .
Patients with EDS Type IV can be expected to have a thin dermis, usually deficient in collagen, fine organization of small fiber bundles and a real or apparent increase in elastic connec tive tissue. Collagen fibrils are usually small in diameter or occur in a dual population based on diameter. Elastic fibers are reticular, branched, fragmented and contain debris-like inclu sions. Pools of diffuse material accumulate in the tissue.
EDS IV is a disorder of Type III collagen metabolism [54, 55] . How this relates to the morphology, however, is totally speculative. Type III collagen comprises only 10-15% of dermal collagen normally and much of this is localized in the papillary dermis, surrounding vessels and in appendage sheathes. Type III fibrils are "thin fibrils" [56] , yet these individuals who lack type III have thin fibrils as the dominant population or as one group of a mixed population. It is interesting that collagen flowers are not seen in patients of type IV EDS.
Inherited (recessive or dominant) cutis laxa can be recognized at the light microscopic level by the small amount of stainable elastic fibers in the reticular dermis and by the small collagen fiber bundles. The elastic fibers appear as specks rather than bands. In nearly every case we have examined, the elastin matrix is deficient and the microfibrils appear excessive and intermixed with collagen. Collagen fibrils are often variable in diameter. Serum elastase inhibition associated with low serum Vol. 79, Supplement 1 copper was an inconsistent finding among patients with cutis laxa [57, 58] . Diminished collagen production is believed to account for the clinical presentation in another patient with cutis laxa (Holbrook KA, Pinnell SR: unpublished observa tions). The cutis laxa-like morphology is also seen in skin after treatment with penicillamine and ,B-APN, lathryogenic com pounds which prevent normal crosslin king by noncompetitive inhibition of the enzyme lysyl oxidase [59] . In only the X-linked form of cutis laxa, however, has decreased lysyl oxidase activity been identified [29] and tissue from this patient appears to be an exception to the morphologic changes in cutis laxa: collagen fibrils are unusually large, fiber bundles are dense and elastic fibrils are normal.
For the other diseases in which structural abnormalities have been recognized, we have not yet examined tissue from an adequate number of patients to permit description of an abnor mal pattern, but for many of them a biochemical defect has been recognized, hence the structural alterations can be pre sented in light of these data. In addition to type I EDS, collagen flowers can form in conditions where there is a molecular defect in one of the collagen chains (EDS VII; [16] ), in enzymes which affect posttranslational modification (lysyl oxidase, EDS V ( [60] , biochemical data in question, [61] ); prolyl hydroxylse, EDS VI [62] and EPS [23] , where secretion of (1'1 (I) chains are 50% the normal amount (0.1. type I, [35] ), when the amount of elastin is elevated several fold (Buschke-Ollendorff, [25] , and in instances where there is a defect in fibronectin as indicated by defective platelet attachment to collagen (EDS IX, [63] ), These abnormal structures account for only a small percentage of the fibrils; the majority of the fibrils in skin of these patients may be normal in shape but abnormally large (EDS III) or small (I, II, VI, Type I 01) in diameter. The conditions under which fibrils of a wide range of diameters occur simultaneously are also varied. The biochemical alterations in EDS, I, II, IV, and VII have been described previously. They are not known for EDS VIn or cutis laxa. What this deviation means in terms of tissue pathology is confusing in view of finding the same di ameter variability in normal papillary dermis of some individ uals and in tendon and fascia.
